Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.8.0.1
Stockholders' Equity (Tables)
6 Months Ended
Dec. 31, 2017
Equity [Abstract]  
Schedule of stock-based compensation expense

The fair values of the warrants were estimated at the dates of grant using a binomial option pricing model with the following weighted average assumptions:

 

Expected term (years)     5.50  
Risk-free interest rate     2.12 %
Volatility     69 %
Dividend yield     0 %
Schedule of Black-Scholes option pricing model with weighted average assumptions

The fair values of the Company’s options were estimated at the dates of grant using a Black-Scholes option pricing model with the following weighted average assumptions:

 

Exercise price     $6.24 – $7.12  
Expected term (years)     4.00 – 7.00  
Risk-free interest rate     1.72 – 2.10 %
Volatility     70 - 88 %
Dividend yield     0 %
Schedule of option activity

The following is a summary of the option activity:

 

      Options    

Weighted 

Average

Exercise 

Price

 
Outstanding - June 30, 2017       160,000     $ 1.50  
Exercisable - June 30, 2017       80,000     $ 1.50  
Granted       1,006,859       6.74  
Exercised              
Forfeited/Cancelled              
Outstanding – December 31, 2017       1,166,859     $ 6.02  
Exercisable – December 31, 2017       80,000     $ 1.50  
Schedule of resricted shares

The following is a summary of restricted stock units (“RSU’s”) and restricted stock awards (“RSA’s”):

 

Grant Date

Shares  

Issued 

   

Fair 

Value (1) 

   

Shares 

Vested 

 
June 2014 (RSA)     307,876     $ 483,284       247,111  
July 2014 (RSA)     32,408       48,612       24,306  
August 2014 (RSA)     81,020       121,179       63,296  
September 2014 (RSA)     129,633       196,313       121,531  
March 2015 (RSA)     72,919       378,109       18,230  
October 2015 (RSA)     293,000       411,000       146,500  
November 2015 (RSA)     36,200       54,300       18,100  
December 2015 (RSA)     300,000       105,000       247,500  
January 2016 (RSA)     40,000       68,000       10,000  
March 2016 (RSA)     60,000             60,000  
June 2016 (RSA)     118,000       533,160       45,000  
August 2016 (RSA)     351,000       1,218,110       40,000  
January 2017 (RSA)     192,000       1,153,951       25,000  
February 2017 (RSA)     110,000       697,500        
March 2017 (RSA)     20,000              
September 2017 (RSA)     111,000       790,320        
September 2017 (RSU)     253,000       1,796,910        
October 2017 (RSU)     301,000       1,872,220        
November 2017 (RSU)     97,494       608,362        
December 2017 (RSU)     120,000       775,800        
                         
      3,026,550     $ 11,312,130       1,066,574  

 

(1) The fair value of the restricted stock awards as shown above is based on either the balance sheet date for consultants or grant date for employees.